"By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria—the energy factories within cells. Doctors might someday use the approach to treat a variety of mito"...
Diamox Sequels Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Diamox Sequels (acetazolamide) is used to treat glaucoma and to treat and to prevent acute mountain sickness (altitude sickness). It is also used as a part of some treatment plans for congestive heart failure and seizure disorders. It is a carbonic anhydrase inhibitor. This medication is available in generic form. Common side effects include dizziness, lightheadedness, and an increased amount of urine, especially during the first few days as your body adjusts to the medication. Blurred vision, dry mouth, drowsiness, loss of appetite, stomach upset, headache and tiredness may also occur.
To treat glaucoma, the recommended dosage of Diamox Sequels is 1 capsule (500 mg) two times a day. To treat acute mountain sickness, dosage is 500 mg to 1000 mg daily, in divided doses using tablets or extended-release capsules as appropriate. Diamox Sequels may interact with cyclosporine, primidone, diflunisal, aspirin and other salicylates, or lithium. Tell your doctor all medications you use. Diamox Sequels should be used during pregnancy only if prescribed. This medication passes into breast milk but is unlikely to harm a nursing infant. Consult your doctor before breast-feeding.
Our Diamox Sequels (acetazolamide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Diamox Sequels in Detail - Patient Information: Side Effects
If you experience any of the following serious side effects, stop taking acetazolamide and seek emergency medical attention:
- an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
- a sore throat or a fever;
- unusual bleeding or bruising;
- side or groin pain;
- tingling or tremors in your hands or feet; or
- a rash.
Other, less serious side effects may be more likely to occur. Continue to take acetazolamide and talk to your doctor if you experience
- decreased appetite, nausea, vomiting, constipation, diarrhea, or changes in taste;
- drowsiness, dizziness, fatigue, or weakness;
- nervousness or mild tremor;
- headache or confusion;
- increased sensitivity of the skin to sunlight;
- worsening gout;
- loss of blood sugar control (if you are diabetic);
- ringing in your ears or hearing problems; or
- changes in your vision.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Diamox Sequels (Acetazolamide XR)
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Diamox Sequels Overview - Patient Information: Side Effects
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor immediately if any of these very unlikely but serious side effects occur: increased body hair, hearing loss, ringing in the ears, unusual tiredness, persistent nausea/vomiting, severe stomach/abdominal pain.
Seek immediate medical attention if any of these unlikely but very serious side effects occur: easy bleeding/bruising, fast/irregular heartbeat, signs of infection (e.g., fever, persistent sore throat), mental/mood changes (e.g., confusion, difficulty concentrating), severe muscle cramps/pain, tingling of the hands/feet, blood in the urine, dark urine, painful urination, yellowing of the eyes/skin.
A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: blisters/sores in the mouth, rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Diamox Sequels (Acetazolamide XR)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Diamox Sequels FDA Prescribing Information: Side Effects
Hepato-biliary disorders:Abnormal liver function, cholestatic jaundice, hepatic insufficiency, fulminant hepatic necrosis
Metabolic/Nutritional:Metabolic acidosis, electrolyte imbalance, including hypokalemia, hyponatremia, osteomalacia with long-term phenytoin therapy, loss of appetite, taste alteration, hyper/hypoglycemia
Special senses:Hearing disturbances, tinnitus, transient myopia
Read the entire FDA prescribing information for Diamox Sequels (Acetazolamide XR)
Additional Diamox Sequels Information
Diamox Sequels - User Reviews
Diamox Sequels User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.